Advanced prostate cancer treatment failure due to cell reprogramming

Researchers have discovered a molecular mechanism that reprograms tumor cells in patients with advanced prostate cancer, reducing their response to anti-androgen therapy. The findings, based on a study in mice, could help to determine which patients should avoid anti-androgen therapy and identify new treatments for people with advanced prostate cancer. (Mehr in: Cancer News — ScienceDaily)